1. Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Issue 7 (7th June 2021) Authors: Fodil, S.; Raffoux, E.; Dumas, P. Y.; Desbrosses, Y.; Larosa, F.; Chantepie, S.; Larcher, M. V.; Mear, J. B.; Peterlin, P.; Hunault-Berger, M.; Hospital, M. A.; Morel, V.; Lucas, N.; Vidal, V.; Salanoubat, C.; Michel, J.; Mediavilla, C.; Ojeda-Uribe, M.; Alexis, M.; Frayfer, J. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 7(2021) Page Start: 1756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗